IONS Stock Conflicts After Ionis Eliminates Huntington’s Roche Partner Treatment
Ionis Pharmaceuticals (IONS) scrapped a Huntington treatment late Monday after an independent committee questioned whether the benefits of the drug outweighed its risks. In response, the IONS stock…
